Bristol Myers Squibb (BMY) Current Deferred Tax Assets (2009 - 2015)

Bristol Myers Squibb (BMY) has 7 years of Current Deferred Tax Assets data on file, last reported at $1.7 billion in Q3 2015.

• Current Deferred Tax Assets for Q3 2015 came in at $1.7 billion, up 14.64% year-over-year; the trailing twelve-month figure through Sep 2015 was $1.7 billion (up 14.64% YoY), and the FY2014 annual result was $1.6 billion, down 3.35% from the prior year.
• Current Deferred Tax Assets fell to $1.7 billion in Q3 2015 per BMY's latest filing, from $1.9 billion in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $2.0 billion in Q3 2013 and troughed at $1.1 billion in Q2 2011.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2014 frame the typical range for Current Deferred Tax Assets.
• The sharpest annual moves came in 2013 and 2014: Current Deferred Tax Assets jumped 66.81% in 2013, then slumped 30.82% in 2014.
• A 5-year view of Current Deferred Tax Assets shows it stood at $1.2 billion in 2011, then surged by 33.08% to $1.6 billion in 2012, then rose by 6.51% to $1.7 billion in 2013, then decreased by 3.35% to $1.6 billion in 2014, then rose by 5.29% to $1.7 billion in 2015.
• Business Quant data shows BMY's Current Deferred Tax Assets at $1.7 billion in Q3 2015, $1.9 billion in Q2 2015, and $1.9 billion in Q1 2015.